We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MDCLF market cap is 1.23B. The company's latest EPS is USD -0.63 and P/E is -44.64.
| Quarter End | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 4.72M | 9.15M | 9.15M | 7.07M | 7.07M |
| Operating Income | -3.8M | -1.58M | -1.58M | -3.31M | -3.31M |
| Net Income | -7.28M | -1.94M | -1.94M | -8.04M | -8.04M |
| Year End March 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 8.19M | 8.34M | 13.66M | 11.95M | 27.73M |
| Operating Income | -18.93M | -23.81M | -24.03M | -20.94M | -10.76M |
| Net Income | -18.99M | -24.81M | -32.01M | -25.04M | -18.44M |
| Quarter End | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 58.86M | 90.45M | 90.45M | 74.58M | 74.58M |
| Total Liabilities | 112.89M | 106.82M | 106.82M | 105.21M | 105.21M |
| Total Equity | -54.03M | -16.37M | -16.37M | -30.63M | -30.63M |
| Year End March 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 63.61M | 44.3M | 29.34M | 36.95M | 90.45M |
| Total Liabilities | 54.48M | 57.67M | 71.63M | 77.77M | 106.82M |
| Total Equity | 9.13M | -13.37M | -42.29M | -40.82M | -16.37M |
| Quarter End | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 10.78M | -1.05M | -1.05M | -7.4M | -7.4M |
| Investing | -3.5M | -3.11M | -3.11M | 4.18M | 4.18M |
| Financing | -1.2M | 17.86M | 17.86M | -1.42M | -1.42M |
| Year End March 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -12.13M | -21.36M | -21.01M | -11.92M | 19.47M |
| Investing | -1.06M | -316k | 1.3M | -613k | -13.21M |
| Financing | 47.92M | -800k | 1.56M | 25.53M | 33.32M |
| Market Cap | 1.235B |
| Price to Earnings Ratio | -44.64 |
| Price to Sales Ratio | 31.30 |
| Price to Cash Ratio | 1.50 |
| Price to Book Ratio | -30.56 |
| Dividend Yield (LTM) | N/A |
| Shares Outstanding | 35.9M |
| Average Volume (1 week) | - |
| Average Volume (1 Month) | - |
| 52 Week Change | 393.00% |
| 52 Week High | 34.39 |
| 52 Week Low | 6.9757 |
| Spread (Intraday) | N/A (N/A%) |
| Company Name | MedinCell (EM) |
| Address |
3 Rue des Frères Lumière Jacou, Languedoc-Roussillon 34830 |
| Website | https://www.medincell.com |
| Industry | Biotechnology & Life Sciences |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Register with Email
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.
Hot Features
Premium
